Clinical trial
Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional…
NCT00348842 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00348842 |
|---|---|
| Title | Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-cancer Modalities |
| Official title | Phase II: Safety and Primary Efficacy of Clinical Application of Newcastle Disease Virus for the Treatment of Patients Resistant to All Conventional Modalities |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer, Newcastle Disease Virus (NDV) |
| Intervention type | Procedure |
| Interventions | Newcastle Virus |
| Start date | Mar 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Jul 6, 2006 |
| Last update posted | Apr 8, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: